Indicateurs
1 Consultations de la notice
- Titre
- TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains
- Créateurs - sans rôle
- Anne-Lise Børresen - Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, NorwayTone Ikdahl Andersen - Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, NorwayJorunn E. Eyfjörd - Icelandic Cancer SocietyRenee S. Cornelis - Departments of Human Genetics and Pathology, University of Leiden, The NetherlandsSteinunn Thorlacius - The Icelandic Cancer Society, Reykjavik, IcelandÅke Borg - Department of Oncology, University Hospital, Lund, SwedenUlla Johansson - Department of Oncology, University Hospital, Lund, SwedenCharles Theillet - Institut de Genetique Moleculaire, Montepellier Cedex, FranceSiegfried Scherneck - Tumorgenetik, Max Delbrück Centrum für Moleculare Medizin, Berlin, GermanySusanne Hartman - Tumorgenetik, Max Delbrück Centrum für Moleculare Medizin, Berlin, GermanyCees J. Cornelisse - Departments of Human Genetics and Pathology, University of Leiden, The NetherlandsEivind Hovig - Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, NorwayPeter Devilee - Departments of Human Genetics and Pathology, University of Leiden, The Netherlands
- Détails de publication
- Genes chromosomes & cancer, Vol.14(1), pp.71-75
- Éditeur
- Wiley Subscription Services, Inc., A Wiley Company
- Nombre de pages
- 5
- Identifiants
- 99162548109311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Journal article